Novel triple-drug therapies are showing promise for patients with various kinds of leukemia, researchers reported at the ...

Three clinical trials led by researchers from The University of Texas MD Anderson Cancer Center demonstrated significant ...

SAN DIEGO ― Three clinical trials led by researchers from The University of Texas MD Anderson Cancer Center demonstrated ...

The first patient has been dosed in the QuANTUM-Wild phase 3 trial evaluating Daiichi Sankyo’s (TSE: 4568) VANFLYTA® ...

Study reveals how socioeconomic factors create barriers to bone marrow transplants for AML patients in disadvantaged ...

The Leukemia & Lymphoma Society (LLS) will present new data from its Beat AML Master Clinical Trial and Pediatric Acute ...

Novel triple-drug therapies are showing promise for patients with various kinds of leukemia, researchers reported at the American Society of Hematology meeting in San Diego.

Fatima Tuz Zahra, MD, discusses the methods and design of a retrospective analysis of 65 patients with acute myeloid leukemia ...

University of Cincinnati Cancer Center experts will present abstracts at the 66th American Society of Hematology (ASH) Annual ...

Phase 2 data show about half of patients with high-risk or secondary acute myeloid leukemia achieved a complete response or ...

Social determinants of health have a more pronounced effect on mortality among patients with acute myeloid leukemia (AML) who ...